Main > ONCOLOGY (**) > Leukemia>Lymphoblastic>Acute *** > USA. S. Clofarabine Inj.>



USA. S. Clofarabine Inj.>'s subsections
(*) USA Approval Date: 2004. 12.28
>Pediatric Patients 1 to 21 Years
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2017. 09.12
Patent>USA Expiration: 2014. 09.21
TradeMark
TradeMark Web-Site

USA. S. Clofarabine Inj.>'s products
This section has no products